Fig. 1.
A general hypothetical framework of comparison of the therapeutic windows of MOP, NOP, and bifunctional NOP/MOP agonists based on current literature. Solid lines indicate the doses at which antinociception/analgesia occurs. Dashed lines indicate the doses at which side effects, especially respiratory depression and sedation, emerge. Reprinted with permission from Lin and Ko (2013)